Trials / Completed
CompletedNCT00448188
Bleeding Risk in CVCs
Thrombocytes and International Normalized Ratio Are no Predictors for Bleeding in Application of Central Veneous Catheters
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- Heidelberg University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Since many of the patients in an intensive care unit suffer from disorders of hemostasis, bleeding is a main concern applying central venous catheters. Even if there are some data indicating elevated international normalized ratio may not increase the risk of bleeding no clear cut-off has been defined so far. An INR \> 1.5 is generally considered to increase the risk of bleeding. Furthermore, many authors consider platelets below 50 x 109 /l as a contra-indication to CVC cannulation, since there are some data this may increase the risk of bleeding. Therefore platelet transfusion before venous puncture is suggested. In our clinical experience INR \> 1.5 and platelets \< 50 x 109 /l do not correlate with increased risk of bleeding. The aim of this study is to demonstrate, that coagulopathy, defined by INR and platelet count, is not decisive for bleeding.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | central venous catheter application |
Timeline
- Start date
- 2005-11-01
- Completion
- 2007-03-01
- First posted
- 2007-03-16
- Last updated
- 2013-01-28
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00448188. Inclusion in this directory is not an endorsement.